Navigation Links
MDS Announces Resolution of Litigation Related to the Sale of MDS Analytical Technologies
Date:1/25/2010

TORONTO, Jan. 25 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that PerkinElmer, Inc. ( PKI) has, pursuant to a settlement agreement, agreed to terminate its litigation against the Company, which was scheduled to be heard in Commercial Court in Toronto today. MDS has a joint-venture with PerkinElmer to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS).

The sale of MDS Analytical Technologies, which was announced on September 2, 2009, is expected to close before the end of the first calendar quarter 2010, subject to receiving regulatory approvals and satisfying closing conditions.

About MDS

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs, and the diagnosis and treatment of disease. We are a leading global provider of innovative technologies for use in medical imaging and radiotherapeutics, sterilization, pharmaceutical contract research, and analytical instruments. MDS has more than 3,500 highly skilled people in 13 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

Caution Concerning Forward-Looking Statements

This document contains forward-looking statements, including statements with respect to the proposed sale of the MDS Analytical Technologies business, and factors that may affect such proposed sale. Some forward-looking statements may be identified by words like "believes", "expects", "anticipates", "plans", "intends", "indicates" or similar expressions. The statements are not a guarantee that the proposed sale will be completed nor a guarantee of future performance, and are inherently subject to risks and uncertainties, including, but not limited to the risks and other factors set forth in reports and other documents filed by MDS with Canadian and U.S. securities regulatory authorities from time to time, including MDS's quarterly and annual MD&A, Annual Information Form, and Annual Report on Form 40-F for the fiscal year ended October 31, 2008, filed with the U.S. Securities & Exchange Commission and the Management Information Circular (dated September 17, 2009).

SOURCE MDS Inc.


'/>"/>
SOURCE MDS Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Agilux Laboratories Announces the Launch of GLP LC/MS/MS Bioanalytical Services
2. ORCS Web, Inc Announces Plans for Employee Ownership
3. Eyre Bus, Tour & Travel Donates Bus to Transport Medical Professionals from D.C. Area to New York for Flight to Haiti, Announces the Greater Washington Haiti Relief Committee and the Embassy of Haiti
4. Forterus Announces Fiscal Year 2009 Financial Results
5. UCLB announces new partnership with Kurma Biofund
6. AXIOM Systems, Inc. Announces General Release of HIPAA 5010 Testing Solutions
7. Universal Health Services, Inc. Announces Dividend
8. GettingHired, LLC Announces the Addition of Al Hemond, Former Prudential SVP of Disability Risk to its FastTrackRTW Team
9. Healthy Directions, LLC, Announces Launch of Online Resource for Premium Quality Natural Health Solutions
10. Healthcare Businesswomens Association Announces 2010 Board of Directors
11. The International Multiple Sclerosis Management Practice Announces Major Expansion Plans to NYC Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to ... available through Jet.com. , After 25 years of development, the company released its ... quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... and call tracking and monitoring solutions, announced today the launch of a redesigned ... a modern navigation and aesthetic, fully responsive design, and an enhanced search directory ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: